Skin News and Research

RSS

Way patients cope with diabetes-related foot ulcers and their levels of depression affect wound healing

People suffering from diabetes-related foot ulcers show different rates of healing according to the way they cope and their psychological state of mind, according to new research by a health psychologist at The University of Nottingham.

3 Aug 2010

Study reveals potential marker for prostate cancer

Studies by a Purdue University-led team have revealed a potential marker for prostate cancer that could be the starting point for less invasive testing and improved diagnosis of the disease.

3 Aug 2010

BioMarin provides update on PEG-PAL Phase 2 clinical study for phenylketonuria

BioMarin Pharmaceutical Inc. announced today an update in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). Data reported in this announcement reflect preliminary results as of July 23, 2010. Complete top-line results are expected in the fourth quarter of 2010.

3 Aug 2010

OECD approves new, non-animal testing guideline for skin irritation

After more than a decade of scientific research and lobbying by animal protection groups, the Organisation for Economic Cooperation and Development (OECD) has approved a new, non-animal testing guideline for skin irritation. The guideline was adopted on July 22 and it is now available for use by companies and governments worldwide.

3 Aug 2010

Pakistani officials fear cholera outbreak after massive flooding

After floods in northwest Pakistan have "already killed up to 1,200 people" and forced 2 million from their homes, authorities are now concerned about disease spread, the Associated Press reports.

2 Aug 2010

BIOTONE announces availability of Cocoa-Comfort Massage Balm

BIOTONE announces Cocoa-Comfort Massage Balm, one of the first balms for the professional massage therapy market. Created from a one-of-a-kind formulation whose leading ingredient Cocoa Butter is nature's ultimate hydrator, the new rich, thick balm gives a slight warming feel when applied at the same time it soothes and balances the skin to enhance its texture and tone.

2 Aug 2010

MBHS targets emerging healthcare markets of Russia, CIS

mBeach Software Inc. today announced a strategy of targeting new international market opportunities. In particular, the company has identified the emerging markets of Russia and Commonwealth of Independent States.

31 Jul 2010

Nuvo Research second-quarter revenue increases 57% to $4.2 million

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the quarter ended June 30, 2010.

31 Jul 2010

Team to execute research strategies surrounding oil spill health outcomes

While oil from the Deepwater Horizon spill may have stopped gushing into the Gulf of Mexico, experts are far from finished working to anticipate, outline and minimize the disaster's potential health risks, says a University of Alabama at Birmingham School of Public Health researcher actively involved in helping the federal government deal with repercussions from the April 20 accident.

31 Jul 2010

Resveratrol suppresses inflammation in humans: Research

Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.

31 Jul 2010

Epigenetic changes to DNA in breast cancers linked with environmental risk factors, tumor size: Study

Researchers from Brown University and the University of California San Francisco have found that epigenetic changes to DNA in breast cancers are related to environmental risk factors and tumor size, providing a window into the severity of the disease. The study is published in today's edition of PLoS Genetics. The researchers found that epigenetic profiles of tumors had a direct association with diet, alcohol, and tumor size.

31 Jul 2010

Despite all advancements in melanoma diagnosis, rapid treatment remains critical: Report

Twenty-five years after publishing the mnemonic "ABCD" to facilitate the early diagnosis of melanoma, the group who came up with that moniker says early detection remains a key factor in lowering mortality from malignant melanoma. Darrell S. Rigel, M.D. and colleagues from the Ronald O. Perelman Department of Dermatology at New York University School of Medicine say that, despite all of the advances in melanoma diagnosis, timely recognition, detection, and rapid treatment of melanoma remain critical.

30 Jul 2010

Intrinsic brain connectivity in fibromyalgia associated with chronic pain intensity

A recent study from researchers at Massachusetts General Hospital and University of Michigan provides the first direct evidence of linkage between elevated intrinsic (resting-state) brain connectivity and spontaneous pain intensity in patients with fibromyalgia (FM). This research shows an interaction of multiple brain networks, offering greater understanding of how pain arises. Details of the study appear online and in the August issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

30 Jul 2010

Resveratrol suppresses inflammation and free radicals: Study

30 Jul 2010

Kiehl's Since 1851 inaugurates LifeRide to raise funds for amfAR

Maintaining its long-standing tradition of supporting HIV/AIDS charities, Kiehl's Since 1851, the venerable New York-based purveyor of fine quality skin and hair care, is pleased to announce a continued partnership with amfAR, The Foundation for AIDS Research.

30 Jul 2010

Life Time Fitness plans to open LifePower Yoga studio in Minnesota

Life Time Fitness, Inc. today announced plans to open its first LifePower Yoga studio in Minnesota. With a planned August 2010 opening, the new location will mark Life Time's 25th center in Minnesota, and its first dedicated solely to yoga and pilates. The company already operates two LifePower studios: LifePower at Pima Crossing, in Scottsdale, Arizona, and LifePower Phoenix.

30 Jul 2010

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.

30 Jul 2010

Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling

Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.

30 Jul 2010

Resting brain activity associated with spontaneous fibromyalgia pain

29 Jul 2010

Senate Commission presents 2010 list of MAK and BAT values containing new data on 61 substances

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the classification of health hazards constituted by work area substances have been adjusted this year.

29 Jul 2010